Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Biovail, Valeant set shareholder merger vote date
Yahoo/AP
Wednesday, August 11, 2010 - 11:11am
tags:
M&A, Biovail, Valeant Pharmaceuticals
DepoMed starts new late-stage Serada trial
Yahoo/AP
Wednesday, August 11, 2010 - 11:11am
tags:
Serada, Depomed, clinical trials, hot flashes
Cardiome shares tumble on heart drug delay
Yahoo/AP
Wednesday, August 11, 2010 - 11:10am
tags:
Cardiome, Merck, atrial fibrillation
When the Disease Matters Most in Drug Approval
Motley Fool
Wednesday, August 11, 2010 - 11:08am
tags:
drug development, JNJ, Vivus, Valeant Pharmaceuticals, GSK, Pfizer, Abbott Laboratories
Technically, MannKind Is a Buy
Motley Fool
Wednesday, August 11, 2010 - 11:03am
tags:
diabetes, inhaled insulin, MannKind, Afrezza
Momenta Poised to Dominate $100B Blood Thinners Industry
Seeking Alpha
Wednesday, August 11, 2010 - 9:53am
tags:
Momenta, blood thinners, biogenerics, Lovenox, Sanofi
Lilly to Indiana: We're shrinking for keeps
Indianapolis Star, IN
Wednesday, August 11, 2010 - 9:19am
tags:
Eli Lilly, layoffs, Indiana
Merck Prostate Cancer Medicine Merits More Attention
Bloomberg
Wednesday, August 11, 2010 - 9:14am
tags:
prostate cancer, Proscar, Merck
Marginal Performance at Abbott Laboratories
Motley Fool
Wednesday, August 11, 2010 - 9:12am
tags:
Abbott Laboratories, Valeant Pharmaceuticals, Merck, Celgene, Bristol-Myers Squibb
Dividend Report Card: AstraZeneca
Motley Fool
Wednesday, August 11, 2010 - 9:12am
tags:
AstraZeneca, dividends
Florida to get $3M in Topamax settlement
Bizjournals.com
Wednesday, August 11, 2010 - 9:11am
tags:
Florida, settlements, Topamax, JNJ
Medivation Narrows Loss
Yahoo/Zacks.com
Wednesday, August 11, 2010 - 9:10am
tags:
earnings, Medivation, Pfizer, AstraZeneca
Popular Bone Drugs Don't Raise Esophageal, Stomach Tumor Risk, Study Finds
Bloomberg
Tuesday, August 10, 2010 - 7:07pm
tags:
stomach cancer, New England Journal of Medicine, osteoporosis, Roche, Boniva, Merck, Fosamax
Sanofi Target Genzyme Says Contamination Fix at Plant May Take Four Years
Bloomberg
Tuesday, August 10, 2010 - 7:05pm
tags:
Genzyme, Sanofi, M&A, contamination
SciClone plunges on SEC, Justice Dept. inquiries
Yahoo/AP
Tuesday, August 10, 2010 - 7:04pm
tags:
SEC, DOJ, SciClone, bribery, Merck
PDL BioPharma's Magic Formula
Motley Fool
Tuesday, August 10, 2010 - 11:34am
tags:
PDL Biopharma
Would Jeremy Grantham Buy Alcon?
Motley Fool
Tuesday, August 10, 2010 - 11:25am
tags:
Alcon, M&A
Johnson & Johnson: Undervalued and Looking Good
Seeking Alpha
Tuesday, August 10, 2010 - 11:21am
tags:
JNJ
Mallinckrodt - Top 10 Generic Drug Companies 2010
Fierce Pharma
Tuesday, August 10, 2010 - 10:35am
tags:
Mallinckrodt, generics
SciClone leads drug sector declines
Marketwatch
Tuesday, August 10, 2010 - 10:32am
tags:
SciClone

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.